Abstract
Background: Two distinct histological patterns, viz., LPSP and IDCP, are seen in AIP (Am J Surg Path 2003:27;1119-27). Methods: We compared the profiles of histologically confirmed LPSP (n = 28) (Features: periductal lympho-plasmacytic infiltrate, storiform fibrosis and obliterative phlebitis without granulocyte epithelial lesions (GELs) and IDCP (n = 13) (Features: prominent neutrophilic infiltrate in the lobule and duct (GELs) with duct destruction.) Results: While LPSP subjects presented more often with obstructive jaundice (25/28 vs 4/13, p < 0.05), IDCP subjects were more likely to be evaluated for pancreatic duct stricture without a mass (3/13 vs 0/28, p < 0.05). LPSP patients were a decade older than IDCP subjects (mean age 61.2 ± 12.4 vs 50.4 ± 19.1, p < 0.05); the proportion of men in both groups was similar (79% vs 69%). Serum IgG4 was elevated in 9/12 LPSP vs 0/2 IDCP. Involvement of proximal bile duct, retroperitoneum, salivary glands or kidney was seen in LPSP but not IDCP (11/28 vs 0/13, p < 0.05). 2 IDCP and 1 LPSP patient had inflammatory bowel disease. All 7 LPSP patients receiving steroids responded; IDCP did not receive steroids as all were diagnosed after resection. Conclusion: LPSP and IDCP appear to be distinct clinical entities for which we propose the terms type I and type II AIP, respectively. IDCP cannot be diagnosed prospectively by current diagnostic criteria as it is not associated serum IgG4 elevation, or other organ involvement.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.